Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cortex Brainwave Technologies is an Australian neurotechnology and digital health company developing non-invasive brain-computer interface headsets and bionic sensors for at-home neurofeedback therapy. The company focuses on hardware and software intended to help people with neurocognitive and neurological conditions, with particular emphasis on autism, ADHD, brain injury, depression, anxiety, and seizure-related disorders. Its approach appears centered on measuring brain activity and using neurofeedback-enabled apps and games to help retrain unhealthy brainwave patterns outside traditional clinic settings. The business is best characterized as an early-stage medical device and neurotechnology platform company rather than a drug developer. Cortex also positions its technology for broader uses in accessibility, human performance, and integration with adjacent tools such as AR/VR and stimulation-based systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cortex Brainwave Technologies.